This r&d- medical: biomedical (basic research) federal contracting opportunity for National Cancer Institute, Health and Human Services, provides research and development in the physical, engineering, and life sciences products and/or services. The original notice was posted on January 30, 2020 and last updated September 22, 2020.
Most recently (September 22, 2020), the award notice notice, response date was moved to null, place of performance was updated to MD 21201, USA, contracting officer contact information was updated, and description was updated.
The civilian buyer (National Cancer Institute) from Health and Human Services spent $1.2B in federal contracting dollars in fiscal year 2020 with a stable budget forecast heading into FY22. National Cancer Institute shows unrestricted competition preference with 8.13% in set aside dollars (versus full and open competiton).
Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.
We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.
Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.
Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.
Federal Compass is software designed for today’s federal market.
Explore how the right intel and process can help lead your team to greater success.
Enjoy instant access to the Federal Compass platform